Abiopharma

🔍 Stav Orit (Director)

Company: CAMTEK LTD (CAMT)

Report Date: 2026-07-29

Detailed Transactions and Holdings:

• Acquired 254 shares of Ordinary Shares (Direct)
  Date: 2026-07-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,819.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 571 shares of Stock Option (Right to Buy) at $147.87 per share (Derivative)
  Date: 2026-07-29 | Code: A | Expires: 2033-07-29 | equity_swap_involved: 0 | shares_owned_after: 571.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: The restricted stock units ("RSUs") reported herein represent a contingent right to receive one share of ordinary stock of Camtek Ltd (the "Company"). All 254 RSUs reported hereby will vest on the date of the Company's 2027 annual meeting of shareholders, subject to the Reporting Person's continued service through such vesting date.
• F2: The Reporting Person was granted stock options to purchase ordinary shares of Camtek Ltd (the "Company") subject to the Reporting Person's continued service through such vesting date.
• F3: The options will vest on the date of the Company's 2027 annual meeting of shareholders, subject to continued service through the vesting date.